Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus. [electronic resource]
Producer: 20070718Description: 282-9 p. digitalISSN:- 0300-0664
- Adiponectin -- blood
- Analysis of Variance
- Biomarkers -- blood
- Blood Glucose -- analysis
- C-Reactive Protein -- analysis
- Diabetes Mellitus, Type 2 -- blood
- Drug Administration Schedule
- Homeostasis
- Humans
- Hypoglycemic Agents -- therapeutic use
- Insulin -- blood
- Insulin Resistance
- Interleukin-18 -- blood
- Interleukin-6 -- blood
- Metformin -- therapeutic use
- Multivariate Analysis
- Resistin -- blood
- Rosiglitazone
- Sulfonylurea Compounds -- therapeutic use
- Thiazolidinediones -- therapeutic use
- Time Factors
- Tumor Necrosis Factor-alpha -- blood
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.